BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 8780425)

  • 1. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
    Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
    Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of dual diagnosis. Substance dependence and psychiatric disorders.
    Bryant KJ; Rounsaville B; Spitzer RL; Williams JB
    J Nerv Ment Dis; 1992 Apr; 180(4):251-7. PubMed ID: 1556565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
    Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
    Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of substance use disorder among psychiatric inpatients with mental illness.
    Dixon L; McNary S; Lehman AF
    Am J Psychiatry; 1998 Feb; 155(2):239-43. PubMed ID: 9464204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of psychiatric diagnoses in patients with substance use disorders: is the interview more important than the interviewer?
    Kranzler HR; Kadden RM; Burleson JA; Babor TF; Apter A; Rounsaville BJ
    Compr Psychiatry; 1995; 36(4):278-88. PubMed ID: 7554872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.
    Rosenberg SD; Drake RE; Wolford GL; Mueser KT; Oxman TE; Vidaver RM; Carrieri KL; Luckoor R
    Am J Psychiatry; 1998 Feb; 155(2):232-8. PubMed ID: 9464203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders.
    Kranzler HR; Kadden RM; Babor TF; Rounsaville BJ
    J Nerv Ment Dis; 1994 May; 182(5):277-83. PubMed ID: 10678309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedural validity of the AUDADIS-5 depression, anxiety and post-traumatic stress disorder modules: Substance abusers and others in the general population.
    Hasin DS; Shmulewitz D; Stohl M; Greenstein E; Aivadyan C; Morita K; Saha T; Aharonovich E; Jung J; Zhang H; Nunes EV; Grant BF
    Drug Alcohol Depend; 2015 Jul; 152():246-56. PubMed ID: 25939727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population.
    Appleby L; Dyson V; Altman E; Luchins DJ
    J Nerv Ment Dis; 1997 Mar; 185(3):159-65. PubMed ID: 9091597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual diagnosis subtypes in urban substance abuse and mental health clinics.
    Hien D; Zimberg S; Weisman S; First M; Ackerman S
    Psychiatr Serv; 1997 Aug; 48(8):1058-63. PubMed ID: 9255839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections.
    Lachner G; Wittchen HU; Perkonigg A; Holly A; Schuster P; Wunderlich U; Türk D; Garczynski E; Pfister H
    Eur Addict Res; 1998 Mar; 4(1-2):28-41. PubMed ID: 9740815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance dependence and eating disorders: impact of sequence on comorbidity.
    Wiseman CV; Sunday SR; Halligan P; Korn S; Brown C; Halmi KA
    Compr Psychiatry; 1999; 40(5):332-6. PubMed ID: 10509613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.